从ADC的发展到肿瘤靶向治疗，在结合方面还有许多值得借鉴的经验。

This whitepaper reviews the latest common challenges and novel strategies for accelerating bioconjugates, across preclinical, research & development and CMC considerations.

It includes:

• Antibody, site, linker & payload combinations to optimize ADCs
• Improved targeting for solid tumors
• 新型有效载荷和运载工具，包括抗体片段-药物、百夫长、肽药物和寡核苷酸结合物

To read the whitepaper, just click on the image below.

Have any questions about the report or interested in sponsoring a future whitepaper? Email andrew.burrows@informa.com.